Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Serum Institute of India

Posted on January 15, 2021January 15, 2021

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…

Continue Reading
Posted on January 8, 2021

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…

Continue Reading
Posted on January 5, 2021January 5, 2021

With hasty approval, India squanders an opportunity to build trust in COVID-19 vaccine

Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take the vaccine. If there is already some degree of anxiety…

Continue Reading
Posted on January 3, 2021

Why people with prior SARS-CoV-2 infection still need to be vaccinated

Since vaccine shortage is expected to last at least for a few months, it may seem appealing to delay or avoid vaccinating those who have been naturally infected. But does…

Continue Reading
Posted on December 28, 2020

Why a dry run for COVID vaccination is needed

This is the first time a vaccine to be administered outside the universal immunisation programme and specifically for adults is to be rolled out. Since several aspects of the COVID vaccination programme are new, the government has rightly decided to undertake a dry-run for vaccine administration.

Continue Reading
Posted on December 19, 2020

COVID-19: Ethical challenges of vaccinating people with comorbidities

Unlike in other groups, national databases of people with comorbidities are not available. However, though not comprehensive, since 2010, State governments have been conducting population-based district level screening to detect…

Continue Reading
Posted on December 12, 2020

Can COVID-19 vaccines with EUA be used at the population level?

Meanwhile, the Indian government has spelt out four high-risk groups — healthcare workers, frontline workers, those over 50 years of age and those aged below 50 years but with co-morbidities…

Continue Reading
Posted on December 11, 2020

By putting the vaccine approval on hold for want of data, DCGI has underscored its priorities

The greatly reassuring decision to seek additional safety and immunogenicity data from the Pune-based Serum Institute of India and Hyderabad’s Bharat Biotech underlines the regulator’s priorities even for emergency use…

Continue Reading

Posts navigation

Page 1 Page 2 … Page 4 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,582 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial January 13, 2021
  • New challenges in conducting COVID-19 vaccine trials in India January 9, 2021
  • I would not take Covaxin without efficacy data: Gagandeep Kang January 8, 2021

Most Read Posts

  • Examination without invigilation - An experiment in trust
  • Vaccine dilemma: To take or not to take Covaxin
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • India's TB control programme renamed to reflect its intent on ending TB
  • 127 papers from India retracted for image duplication, manipulation
  • UGC’s revised white list has 71 active predatory journals
  • UGC removes 4,305 journals from White list, including the Lancet Public Health
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,582 other followers

Archives

Cancel